Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cristina Guarducci, Ph.D.

Concepts (71)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Receptors, Estrogen10202422090.910 Why?
Cyclin-Dependent Kinases120246550.720 Why?
Proto-Oncogene Proteins c-myc120249880.620 Why?
Cell Cycle1202429320.510 Why?
Cyclin-Dependent Kinase 4420245610.480 Why?
Breast Neoplasms132024210190.450 Why?
Protein Kinase Inhibitors3202456720.410 Why?
Drug Resistance, Neoplasm4202453050.400 Why?
Receptor, erbB-27202425570.380 Why?
Piperazines4202425230.350 Why?
Cyclin-Dependent Kinase 6320213500.320 Why?
Apoptosis2202494900.320 Why?
Pyridines4202428750.320 Why?
Antineoplastic Agents, Hormonal3201615200.210 Why?
Signal Transduction32024234470.200 Why?
Carcinoma, Lobular120224810.150 Why?
Genes, Retinoblastoma120181250.150 Why?
Xenograft Model Antitumor Assays1202436050.130 Why?
Carcinoma, Ductal, Breast1202210850.120 Why?
NF-kappa B1202324900.120 Why?
Neoplastic Cells, Circulating120219460.110 Why?
Retinoblastoma Protein120166720.100 Why?
Cell Line, Tumor32024169900.100 Why?
Estradiol2201619370.100 Why?
Cell Proliferation12024104510.080 Why?
Gene Expression Regulation, Neoplastic1202485540.070 Why?
Antineoplastic Agents22021136420.060 Why?
Tamoxifen220229650.060 Why?
Antineoplastic Combined Chemotherapy Protocols22020117420.050 Why?
Female1320243927050.050 Why?
Retinoblastoma Binding Proteins120211010.040 Why?
Apoptosis Regulatory Proteins1202311360.040 Why?
Antigen Presentation1202312510.040 Why?
Mitochondrial Proteins120239760.040 Why?
E2F2 Transcription Factor12016350.030 Why?
Mice12024815390.030 Why?
Cell Count1202118350.030 Why?
Humans1320247615960.030 Why?
Postmenopause2201625130.030 Why?
E2F1 Transcription Factor120161780.030 Why?
Receptors, Progesterone1202111290.030 Why?
Transcription Factor AP-212016800.030 Why?
Hepatocyte Nuclear Factor 3-alpha120161640.030 Why?
Biomarkers, Pharmacological120161610.030 Why?
Bayes Theorem1202323300.030 Why?
Animals220241684750.030 Why?
Phosphatidylinositol 3-Kinases1202428650.030 Why?
Intracellular Signaling Peptides and Proteins1202328720.030 Why?
Epidermal Growth Factor120167020.030 Why?
Tumor Cells, Cultured1202161310.030 Why?
Ubiquitin-Protein Ligases1202118990.020 Why?
Gene Expression Profiling2201894200.020 Why?
Aromatase Inhibitors120155130.020 Why?
Chromatin1202229610.020 Why?
Tumor Microenvironment1202338780.020 Why?
ROC Curve1201835780.020 Why?
Prognosis22022296290.020 Why?
Neoadjuvant Therapy1201828280.020 Why?
Disease-Free Survival1201668150.020 Why?
Neoplasm Metastasis1201549150.010 Why?
Disease Progression12021135100.010 Why?
Survival Analysis12016100900.010 Why?
Neoplasm Staging12018111200.010 Why?
Treatment Outcome22021646850.010 Why?
Double-Blind Method12016123410.010 Why?
Aged, 80 and over12018589840.010 Why?
Middle Aged220182209210.010 Why?
Mutation12016300530.010 Why?
Young Adult12018592600.010 Why?
Aged120181693100.000 Why?
Adult120182212100.000 Why?
Guarducci's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (23)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.